WO2010151004A3 - 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물 - Google Patents
하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물 Download PDFInfo
- Publication number
- WO2010151004A3 WO2010151004A3 PCT/KR2010/003937 KR2010003937W WO2010151004A3 WO 2010151004 A3 WO2010151004 A3 WO 2010151004A3 KR 2010003937 W KR2010003937 W KR 2010003937W WO 2010151004 A3 WO2010151004 A3 WO 2010151004A3
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- local administration
- injectable composition
- composition containing
- treating hemorrhoids
- hydroxychloroquine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/08—Solutions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
- A61K31/4706—4-Aminoquinolines; 8-Aminoquinolines, e.g. chloroquine, primaquine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0031—Rectum, anus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P23/00—Anaesthetics
- A61P23/02—Local anaesthetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P39/00—General protective or antinoxious agents
- A61P39/06—Free radical scavengers or antioxidants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/14—Vasoprotectives; Antihaemorrhoidals; Drugs for varicose therapy; Capillary stabilisers
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Anesthesiology (AREA)
- Vascular Medicine (AREA)
- Heart & Thoracic Surgery (AREA)
- Biochemistry (AREA)
- Cardiology (AREA)
- Toxicology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Abstract
Priority Applications (7)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP10792286.6A EP2468257A4 (en) | 2009-06-23 | 2010-06-18 | INJECTABLE COMPOSITION CONTAINING HYDROXYCHLOROQUINE FOR LOCAL ADMINISTRATION FOR THE TREATMENT OF HEMORRHOIDS |
JP2012517374A JP5342695B2 (ja) | 2009-06-23 | 2010-06-18 | ヒドロキシクロロキンを含有する痔核治療のための局所投与用注射剤組成物 |
BRPI1010072A BRPI1010072A2 (pt) | 2009-06-23 | 2010-06-18 | composição injetavel contendo hidroxicloroquina para administração local para o tratamento de hemorróida |
US13/379,626 US8871228B2 (en) | 2009-06-23 | 2010-06-18 | Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids |
RU2012100621/15A RU2530605C2 (ru) | 2009-06-23 | 2010-06-18 | Композиция для инъекций, содержащая гидроксихлорохин, для местного применения при лечении геморроя |
AU2010263478A AU2010263478A1 (en) | 2009-06-23 | 2010-06-18 | Injectable composition containing hydroxychloroquine for local administration for treating hemorrhoids |
CN2010800280712A CN102481252A (zh) | 2009-06-23 | 2010-06-18 | 含有羟基氯喹的用于痔核治疗的局部投药用注射剂组合物 |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR10-2009-0055860 | 2009-06-23 | ||
KR1020090055860A KR101067443B1 (ko) | 2009-06-23 | 2009-06-23 | 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물 |
Publications (3)
Publication Number | Publication Date |
---|---|
WO2010151004A2 WO2010151004A2 (ko) | 2010-12-29 |
WO2010151004A3 true WO2010151004A3 (ko) | 2011-05-19 |
WO2010151004A9 WO2010151004A9 (ko) | 2011-07-07 |
Family
ID=43387010
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/KR2010/003937 WO2010151004A2 (ko) | 2009-06-23 | 2010-06-18 | 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물 |
Country Status (9)
Country | Link |
---|---|
US (1) | US8871228B2 (ko) |
EP (1) | EP2468257A4 (ko) |
JP (1) | JP5342695B2 (ko) |
KR (1) | KR101067443B1 (ko) |
CN (1) | CN102481252A (ko) |
AU (1) | AU2010263478A1 (ko) |
BR (1) | BRPI1010072A2 (ko) |
RU (1) | RU2530605C2 (ko) |
WO (1) | WO2010151004A2 (ko) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR101253565B1 (ko) | 2009-09-22 | 2013-04-11 | 삼성전자주식회사 | 디스플레이 장치 |
KR101698003B1 (ko) | 2016-06-20 | 2017-01-19 | 여오영 | 퀴닌 염 현탁액을 포함하는 항암 치료를 위한 국소 투여용 주사제 조성물 |
RU2657511C2 (ru) * | 2016-08-15 | 2018-06-14 | Общество с ограниченной ответственностью "ИБМХ-ЭкоБиоТех" (ООО "ИБМХ-ЭкоБиоТех") | Способ получения фармакопейного экстракта |
CN115317483A (zh) * | 2021-12-24 | 2022-11-11 | 南通大学附属医院 | 氯喹及其衍生物在制备PGCCs抑制剂中的应用 |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020040767A (ko) * | 1999-08-03 | 2002-05-30 | 아베데 파르마 게엠베하 운트 콤파니 카게 | 개와 고양이에서 퇴행성 관절 질환으로 인한 통증을경감시키기 위한 플루피르틴의 용도 |
Family Cites Families (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20050090553A1 (en) * | 1992-06-30 | 2005-04-28 | Shapiro Howard K. | Compositions and method for treatment of chronic inflammatory diseases |
DE19634313A1 (de) * | 1996-08-24 | 1998-02-26 | Behringwerke Ag | Methode zur Stabilisierung von Plättchen |
RU2174396C2 (ru) * | 1997-03-20 | 2001-10-10 | Панацея Биотек Лтд. | Фармацевтическая композиция для подавления и лечения аноректальных и ободочно-кишечных болезней |
US20060079492A1 (en) * | 1999-10-25 | 2006-04-13 | Ahlem Clarence N | Compositions and treatment methods |
WO2002009714A1 (en) | 2000-07-31 | 2002-02-07 | Cellegy Pharmaceuticals, Inc. | Compositions and methods for the treatment of anorectal disorders |
KR100390332B1 (ko) * | 2000-08-02 | 2003-07-07 | 유원민 | 항말라리아제와 항암제의 병용투여에 의한 항암제 복합 조성물 |
EP1450803A4 (en) * | 2001-11-09 | 2008-09-03 | Lauren Charous | NEW USES FOR ANTIMALARIAL THERAPEUTIC AGENTS |
AU2003287100A1 (en) * | 2002-11-08 | 2004-06-03 | Kin-Ping Wong | Compositions containing an active fraction isolated from lycium barbarum and methods of using the same |
AU2003287099A1 (en) * | 2002-11-08 | 2004-06-03 | Kin-Ping Wong | Extract of trapa natans and methods of using the same |
JP4791682B2 (ja) | 2003-02-21 | 2011-10-12 | 帝國製薬株式会社 | 痔疾患用治療剤 |
JP4239036B2 (ja) * | 2005-02-21 | 2009-03-18 | ラウト,ラジーブ | 改良薬剤組成物 |
US20080221150A1 (en) * | 2005-08-13 | 2008-09-11 | Shacka John J | Prevention of Neurodegeneration by Macrolide Antibiotics |
KR20080105857A (ko) | 2007-06-01 | 2008-12-04 | 주식회사 비앤씨엘 | 치질환 및 기타 항문 직장 질환 치료 활성을 가지는조성물과 이의 제조 방법 및 이를 이용한 치질환 치료제 |
-
2009
- 2009-06-23 KR KR1020090055860A patent/KR101067443B1/ko active IP Right Grant
-
2010
- 2010-06-18 JP JP2012517374A patent/JP5342695B2/ja not_active Expired - Fee Related
- 2010-06-18 US US13/379,626 patent/US8871228B2/en not_active Expired - Fee Related
- 2010-06-18 EP EP10792286.6A patent/EP2468257A4/en not_active Withdrawn
- 2010-06-18 CN CN2010800280712A patent/CN102481252A/zh active Pending
- 2010-06-18 AU AU2010263478A patent/AU2010263478A1/en not_active Abandoned
- 2010-06-18 BR BRPI1010072A patent/BRPI1010072A2/pt not_active IP Right Cessation
- 2010-06-18 WO PCT/KR2010/003937 patent/WO2010151004A2/ko active Application Filing
- 2010-06-18 RU RU2012100621/15A patent/RU2530605C2/ru not_active IP Right Cessation
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
KR20020040767A (ko) * | 1999-08-03 | 2002-05-30 | 아베데 파르마 게엠베하 운트 콤파니 카게 | 개와 고양이에서 퇴행성 관절 질환으로 인한 통증을경감시키기 위한 플루피르틴의 용도 |
Non-Patent Citations (3)
Title |
---|
CLARK, P. ET AL.: "Hydroxychloroquine Compared with Placebo in Rheumatoid Arthritis.", ANNALS OF INTERNAL MEDICINE., vol. 119, no. 11, 1993, pages 1067 - 1071, XP008148632 * |
O'DELL, J. R. ET AL.: "Treatment of Rhenumatoid Arthritis with Methotrexate alone, Sulfasalzine and Hydroxychloroquine, or a Combination of All Three Medications.", THE NEW ENGLAND JOURNAL OF MEDICINE., vol. 334, no. 20, 1996, pages 1287 - 1291, XP008141323 * |
RAOULT, D. ET AL.: "Treatment of Q Fever Endocarditis.", ARCH INTERN MED., vol. 159, 1999, pages 167 - 173, XP008148641 * |
Also Published As
Publication number | Publication date |
---|---|
KR20100137692A (ko) | 2010-12-31 |
BRPI1010072A2 (pt) | 2016-03-15 |
US8871228B2 (en) | 2014-10-28 |
CN102481252A (zh) | 2012-05-30 |
WO2010151004A9 (ko) | 2011-07-07 |
US20120108633A1 (en) | 2012-05-03 |
RU2012100621A (ru) | 2013-07-27 |
EP2468257A2 (en) | 2012-06-27 |
JP5342695B2 (ja) | 2013-11-13 |
RU2530605C2 (ru) | 2014-10-10 |
AU2010263478A1 (en) | 2012-02-02 |
EP2468257A4 (en) | 2014-02-19 |
JP2012530777A (ja) | 2012-12-06 |
WO2010151004A2 (ko) | 2010-12-29 |
KR101067443B1 (ko) | 2011-09-27 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
EA201300898A1 (ru) | Композиция для окислительного фотоактивируемого омоложения кожи, содержащая гиалуроновую кислоту, глюкозамин или аллантоин | |
GB201216932D0 (en) | Use of cannabinoids in combinationwith an anti-psychotic medicament | |
CO6440531A2 (es) | 2-acetamido-5-aril-1,2,4-triazolonas sustituidas y su uso | |
WO2012024620A3 (en) | Autotaxin inhibitors and uses thereof | |
ES2356883A1 (es) | Composicion para el tratamiento del dolor y/o la inflamacion. | |
MX2008011633A (es) | Aminoquinolonas como inhibidores de gsk-3. | |
MX2011011854A (es) | Dihidropirimidinonas para uso como inhibidores de la bace2. | |
NZ608673A (en) | Therapeutic use of a tlr agonist and combination therapy | |
MX346003B (es) | Composiciones orales antibacterianas. | |
WO2011069010A3 (en) | Amantadine compositions and methods of use | |
HK1162502A1 (en) | Cyanoaminoquinolones and tetrazoloaminoquinolones as gsk-3 inhibitors gsk-3 | |
MX2010000266A (es) | Un método para disminuir los síntomas del consumo de alcohol. | |
CO6410278A2 (es) | Disoluciones pediátricas que continen un beta-bloqueante | |
WO2010151004A3 (ko) | 하이드록시클로로퀸을 함유하는 치핵 치료를 위한 국소투여용 주사제 조성물 | |
WO2014071168A3 (en) | Administering inhibitors of tgfbeta signaling to improve muscle function in cancer patients | |
MA32416B1 (fr) | 7-sulfanylmethyl-, 7-sulfinymethyl-et 7-sulfonylmethyl-indoles substitues et leur utilisation | |
WO2011039629A3 (es) | Fracción bioactiva de petiveria alliacea, composición farmacéutica que la contiene y combinación con agentes inmunoestimulantes para el tratamiento del cáncer | |
MX2016006927A (es) | Compuesto de la familia de la avermectina o de la familia de la milbemicina para el tratamiento y/o la prevencion de la dermatitis atopica. | |
MX2010011401A (es) | Asociacion de la dronedarona con al menos un diuretico, su aplicacion en terapeutica. | |
MX337145B (es) | Composiciones farmaceuticas. | |
WO2008139313A8 (es) | Solución anestésica transparente de propofolol, con baja irritación venosa | |
UA92423C2 (ru) | Антибактериальная композиция | |
WO2011069149A3 (en) | Cathepsin s inhibitors | |
UA29207U (ru) | Способ лечения невынашеваемости беременности | |
EA201290285A1 (ru) | Многослойная фармацевтическая композиция, диспергируемая в воде, содержащая комбинацию противомалярийных средств |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
WWE | Wipo information: entry into national phase |
Ref document number: 201080028071.2 Country of ref document: CN |
|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 10792286 Country of ref document: EP Kind code of ref document: A2 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 13379626 Country of ref document: US |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012517374 Country of ref document: JP |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010792286 Country of ref document: EP |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
WWE | Wipo information: entry into national phase |
Ref document number: 40/MUMNP/2012 Country of ref document: IN |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2010263478 Country of ref document: AU |
|
WWE | Wipo information: entry into national phase |
Ref document number: 2012100621 Country of ref document: RU |
|
ENP | Entry into the national phase |
Ref document number: 2010263478 Country of ref document: AU Date of ref document: 20100618 Kind code of ref document: A |
|
REG | Reference to national code |
Ref country code: BR Ref legal event code: B01A Ref document number: PI1010072 Country of ref document: BR |
|
ENP | Entry into the national phase |
Ref document number: PI1010072 Country of ref document: BR Kind code of ref document: A2 Effective date: 20111222 |